Eiji Torikai

561 total citations
24 papers, 463 citations indexed

About

Eiji Torikai is a scholar working on Rheumatology, Oncology and Immunology. According to data from OpenAlex, Eiji Torikai has authored 24 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Eiji Torikai's work include Rheumatoid Arthritis Research and Therapies (12 papers), Spondyloarthritis Studies and Treatments (4 papers) and Musculoskeletal synovial abnormalities and treatments (3 papers). Eiji Torikai is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Spondyloarthritis Studies and Treatments (4 papers) and Musculoskeletal synovial abnormalities and treatments (3 papers). Eiji Torikai collaborates with scholars based in Japan. Eiji Torikai's co-authors include Yasunori Kageyama, Akira Nagano, Masaaki Takahashi, Kunio Tsujimura, M Takahashi, Hayato Kobayashi, Yukio Koide, Masakatsu Suzuki, Susumu Terakawa and Tôru Hirano and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Clinical Biochemistry.

In The Last Decade

Eiji Torikai

24 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiji Torikai Japan 13 216 190 87 85 80 24 463
Véronique Chobaz Switzerland 10 263 1.2× 172 0.9× 89 1.0× 61 0.7× 312 3.9× 18 645
Koji Takasugi Japan 6 97 0.4× 103 0.5× 37 0.4× 37 0.4× 198 2.5× 12 394
Amal Mohamad El‐Barbary Egypt 9 155 0.7× 61 0.3× 54 0.6× 61 0.7× 45 0.6× 24 324
Silvia Bilia Italy 4 265 1.2× 112 0.6× 30 0.3× 63 0.7× 148 1.9× 8 495
Bojana Stamenković Serbia 11 166 0.8× 110 0.6× 31 0.4× 37 0.4× 64 0.8× 41 449
Yeon Sik Hong South Korea 17 372 1.7× 180 0.9× 46 0.5× 40 0.5× 113 1.4× 35 632
Ved Chaturvedi India 9 159 0.7× 105 0.6× 31 0.4× 42 0.5× 75 0.9× 23 340
Cheryl Smythe United Kingdom 5 74 0.3× 94 0.5× 96 1.1× 11 0.1× 135 1.7× 9 464
A. Herrmann Germany 6 65 0.3× 168 0.9× 191 2.2× 11 0.1× 181 2.3× 9 667
Anita W.L. Tsang Hong Kong 14 41 0.2× 155 0.8× 81 0.9× 87 1.0× 171 2.1× 16 641

Countries citing papers authored by Eiji Torikai

Since Specialization
Citations

This map shows the geographic impact of Eiji Torikai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Torikai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Torikai more than expected).

Fields of papers citing papers by Eiji Torikai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Torikai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Torikai. The network helps show where Eiji Torikai may publish in the future.

Co-authorship network of co-authors of Eiji Torikai

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Torikai. A scholar is included among the top collaborators of Eiji Torikai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Torikai. Eiji Torikai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Torikai, Eiji, Daisuke Suzuki, Masakatsu Suzuki, & Yukihiro Matsuyama. (2018). AB0222 Differences of disease impression and treatment expectation in rheumatoid arthritis patients with different disease activity. Annals of the Rheumatic Diseases. 77. 1295–1295. 1 indexed citations
5.
Kageyama, Yasunori, et al.. (2011). Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33. Modern Rheumatology. 22(1). 89–93. 34 indexed citations
6.
Ohishi, Tsuyoshi, Eiji Torikai, Daisuke Suzuki, Tomohiro Banno, & Yosuke Honda. (2010). Arthroscopic treatment of a medial meniscal cyst using a posterior trans-septal approach: a case report. BMC Sports Science Medicine and Rehabilitation. 2(1). 25–25. 8 indexed citations
7.
Kageyama, Yasunori, et al.. (2008). Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis.. PubMed. 26(1). 73–80. 61 indexed citations
8.
9.
Kageyama, Yasunori, et al.. (2007). Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis. Rheumatology International. 28(3). 245–251. 57 indexed citations
10.
Kageyama, Yasunori, et al.. (2007). Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis. Modern Rheumatology. 17(5). 398–402. 7 indexed citations
11.
Kageyama, Yasunori, et al.. (2007). Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis. Modern Rheumatology. 17(5). 398–402. 12 indexed citations
12.
Torikai, Eiji, Yasunori Kageyama, Eiji Kohno, et al.. (2007). Photodynamic therapy using talaporfin sodium for synovial membrane from rheumatoid arthritis patients and collagen-induced arthritis rats. Clinical Rheumatology. 27(6). 751–761. 18 indexed citations
13.
Kageyama, Yasunori, et al.. (2007). Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis. Rheumatology International. 28(2). 137–143. 57 indexed citations
14.
Torikai, Eiji, et al.. (2006). The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis. Lara D. Veeken. 45(6). 761–764. 29 indexed citations
15.
Kageyama, Yasunori, et al.. (2006). Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis. Clinical Rheumatology. 26(4). 505–509. 29 indexed citations
16.
Torikai, Eiji, et al.. (2006). The occurrence of a geode in the olecranon of a patient with rheumatoid arthritis. Archives of Orthopaedic and Trauma Surgery. 126(2). 111–112. 3 indexed citations
17.
Kageyama, Yasunori, Eiji Torikai, & Akira Nagano. (2006). Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis. Rheumatology International. 27(5). 467–472. 30 indexed citations
18.
Torikai, Eiji, Yasunori Kageyama, Masaaki Takahashi, & Akira Nagano. (2006). The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis. Modern Rheumatology. 16(6). 350–354. 21 indexed citations
19.
Torikai, Eiji, et al.. (2006). The effect of infliximab on chemokines in patients with rheumatoid arthritis. Clinical Rheumatology. 26(7). 1088–1093. 22 indexed citations
20.
Torikai, Eiji, Yasunori Kageyama, Masaaki Takahashi, & Akira Nagano. (2006). The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis. Modern Rheumatology. 16(6). 350–354. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Chobaz Breakdown of academic impact, for papers by Koji Takasugi Breakdown of academic impact, for papers by Amal Mohamad El‐Barbary Breakdown of academic impact, for papers by Silvia Bilia Breakdown of academic impact, for papers by Bojana Stamenković Breakdown of academic impact, for papers by Yeon Sik Hong Breakdown of academic impact, for papers by Ved Chaturvedi Breakdown of academic impact, for papers by Cheryl Smythe Breakdown of academic impact, for papers by A. Herrmann Breakdown of academic impact, for papers by Anita W.L. Tsang
Rankless by CCL
2026